Iron dextran

右旋糖酐铁

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameIron dextran
Drug Alias NameDemir DekstranIron-Dextran ComplexHierro dextranoInfedCosmoFer +[6] 
ClassificationSmall molecules
Mechanisms of ActionIron Supplements
TargetsNot applicable
Therapy Area/IndicationsCritical IllnessAnemia, Iron-DeficiencyAnemia +[4] 
Global Approved IndicationsAnemia, Iron-Deficiency
Approved Indications in ChinaAnemia, Iron-Deficiency
Original Approved Country/TerritoryUnited States
Original Approved Date1957/04/25
Country/TerritoryCanadaUnited StatesEgypt +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAmerican Regent IncNational Heart, Lung, And Blood Institute (Nhlbi)Sichuan Xin Kai Yuan Pharmaceutical Co Ltd
Inactive CompaniesIndiana UniversitySanofi-Aventis U.S. LlcAssiut University
Active IndicationsCritical IllnessAnemia, Iron-DeficiencyAnemia
Inactive IndicationsMelanoma

Other Information

ATC CodeB05AA05
Related LinksWikipediaDrugBankKEGG